FI3679158T3 - Yksittäisimmunoglobuliini-interleukiini-1-reseptoriin liittyvän proteiinin (SIGIRR) variantteja ja niiden käyttöjä - Google Patents
Yksittäisimmunoglobuliini-interleukiini-1-reseptoriin liittyvän proteiinin (SIGIRR) variantteja ja niiden käyttöjä Download PDFInfo
- Publication number
- FI3679158T3 FI3679158T3 FIEP18779488.8T FI18779488T FI3679158T3 FI 3679158 T3 FI3679158 T3 FI 3679158T3 FI 18779488 T FI18779488 T FI 18779488T FI 3679158 T3 FI3679158 T3 FI 3679158T3
- Authority
- FI
- Finland
- Prior art keywords
- truncated
- seq
- nucleic acid
- acid sequence
- sigirr protein
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/06—Gastro-intestinal diseases
- G01N2800/065—Bowel diseases, e.g. Crohn, ulcerative colitis, IBS
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Analytical Chemistry (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762554857P | 2017-09-06 | 2017-09-06 | |
| PCT/US2018/049478 WO2019050899A1 (en) | 2017-09-06 | 2018-09-05 | SINGLE IMMUNOGLOBULIN INTERLEUKIN 1 (SIGIRR) RELATED INTERCEPTOR-RELATED VARIANTS AND USES THEREOF |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| FI3679158T3 true FI3679158T3 (fi) | 2025-06-18 |
Family
ID=63708447
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FIEP18779488.8T FI3679158T3 (fi) | 2017-09-06 | 2018-09-05 | Yksittäisimmunoglobuliini-interleukiini-1-reseptoriin liittyvän proteiinin (SIGIRR) variantteja ja niiden käyttöjä |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20210071251A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3679158B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7237064B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR102752108B1 (cg-RX-API-DMAC7.html) |
| CN (1) | CN111373053B (cg-RX-API-DMAC7.html) |
| AU (1) | AU2018328120B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3074652A1 (cg-RX-API-DMAC7.html) |
| DK (1) | DK3679158T3 (cg-RX-API-DMAC7.html) |
| ES (1) | ES3034207T3 (cg-RX-API-DMAC7.html) |
| FI (1) | FI3679158T3 (cg-RX-API-DMAC7.html) |
| IL (1) | IL272940B2 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2020002643A (cg-RX-API-DMAC7.html) |
| NZ (1) | NZ762152A (cg-RX-API-DMAC7.html) |
| SG (1) | SG11202001754RA (cg-RX-API-DMAC7.html) |
| WO (1) | WO2019050899A1 (cg-RX-API-DMAC7.html) |
Family Cites Families (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4399216A (en) | 1980-02-25 | 1983-08-16 | The Trustees Of Columbia University | Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials |
| US5179017A (en) | 1980-02-25 | 1993-01-12 | The Trustees Of Columbia University In The City Of New York | Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials |
| US4634665A (en) | 1980-02-25 | 1987-01-06 | The Trustees Of Columbia University In The City Of New York | Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials |
| US4751180A (en) | 1985-03-28 | 1988-06-14 | Chiron Corporation | Expression using fused genes providing for protein product |
| US4935233A (en) | 1985-12-02 | 1990-06-19 | G. D. Searle And Company | Covalently linked polypeptide cell modulators |
| US5294533A (en) | 1988-07-05 | 1994-03-15 | Baylor College Of Medicine | Antisense oligonucleotide antibiotics complementary to the macromolecular synthesis operon, methods of treating bacterial infections and methods for identification of bacteria |
| US5135917A (en) | 1990-07-12 | 1992-08-04 | Nova Pharmaceutical Corporation | Interleukin receptor expression inhibiting antisense oligonucleotides |
| US5271941A (en) | 1990-11-02 | 1993-12-21 | Cho Chung Yoon S | Antisense oligonucleotides of human regulatory subunit RI.sub.α of cAMP-dependent protein kinases |
| US5786138A (en) | 1993-01-29 | 1998-07-28 | Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College | Hyperstabilizing antisense nucleic acid binding agents |
| AU693097B2 (en) | 1993-06-04 | 1998-06-25 | Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The | Method for treating kaposi's sarcoma with antisense oligonucleotides |
| US5578716A (en) | 1993-12-01 | 1996-11-26 | Mcgill University | DNA methyltransferase antisense oligonucleotides |
| US5641754A (en) | 1994-01-10 | 1997-06-24 | The Board Of Regents Of The University Of Nebraska | Antisense oligonucleotide compositions for selectively killing cancer cells |
| EP0775204A1 (en) | 1994-08-09 | 1997-05-28 | Novartis AG | Antitumor antisense oligonucleotides |
| US5856103A (en) | 1994-10-07 | 1999-01-05 | Board Of Regents The University Of Texas | Method for selectively ranking sequences for antisense targeting |
| US5994320A (en) | 1995-02-06 | 1999-11-30 | Regents Of The University Of Minnesota | Antisense oligonucleotides and methods for treating central nervous system tumors |
| IT1275862B1 (it) | 1995-03-03 | 1997-10-24 | Consiglio Nazionale Ricerche | Trascritto antisenso associato ad alcuni tipi di cellule tumorali ed oligodeossinucleotidi sintetici utili nella diagnosi e nel trattamento |
| US6040296A (en) | 1995-06-07 | 2000-03-21 | East Carolina University | Specific antisense oligonucleotide composition & method for treatment of disorders associated with bronchoconstriction and lung inflammation |
| WO1997014709A1 (en) | 1995-10-13 | 1997-04-24 | F. Hoffmann-La Roche Ag | Antisense oligomers |
| JPH11507245A (ja) | 1995-11-21 | 1999-06-29 | アイシーエヌ・ファーマシューティカルズ・インコーポレイテッド | Ｉｌ―８およびｉｌ―８受容体に対するアンチセンスオリゴヌクレオチドによる睡瘍増殖の阻害 |
| AU708535B2 (en) | 1996-02-15 | 1999-08-05 | Cleveland Clinic Foundation, The | RNase L activators and antisense oligonucleotides effective to treat RSV infections |
| US5955590A (en) | 1996-07-15 | 1999-09-21 | Worcester Foundation For Biomedical Research | Conjugates of minor groove DNA binders with antisense oligonucleotides |
| US6046004A (en) | 1997-02-27 | 2000-04-04 | Lorne Park Research, Inc. | Solution hybridization of nucleic acids with antisense probes having modified backbones |
| JPH1142091A (ja) | 1997-07-25 | 1999-02-16 | Toagosei Co Ltd | アンチセンス核酸化合物 |
| US6046319A (en) | 1997-10-22 | 2000-04-04 | University Technologies International, Inc. | Antisense oligodeoxynucleotides regulating expression of TNF-α |
| IL136696A0 (en) * | 1997-12-23 | 2001-06-14 | Immunex Corp | Sigirr dna and polypeptides |
| US6007995A (en) | 1998-06-26 | 1999-12-28 | Isis Pharmaceuticals Inc. | Antisense inhibition of TNFR1 expression |
| US6013522A (en) | 1999-02-23 | 2000-01-11 | Isis Pharmaceuticals Inc. | Antisense inhibition of human Smad1 expression |
| US6025198A (en) | 1999-06-25 | 2000-02-15 | Isis Pharmaceuticals Inc. | Antisense modulation of Ship-2 expression |
| US6033910A (en) | 1999-07-19 | 2000-03-07 | Isis Pharmaceuticals Inc. | Antisense inhibition of MAP kinase kinase 6 expression |
| WO2013176772A1 (en) | 2012-05-25 | 2013-11-28 | The Regents Of The University Of California | Methods and compositions for rna-directed target dna modification and for rna-directed modulation of transcription |
| LT3138910T (lt) | 2012-12-06 | 2017-11-10 | Sigma-Aldrich Co. Llc | Crispr pagrįstas genomo modifikavimas ir reguliavimas |
| EP4230648A3 (en) | 2016-07-28 | 2023-10-18 | Regeneron Pharmaceuticals, Inc. | Gpr156 variants and uses thereof |
-
2018
- 2018-09-05 DK DK18779488.8T patent/DK3679158T3/da active
- 2018-09-05 WO PCT/US2018/049478 patent/WO2019050899A1/en not_active Ceased
- 2018-09-05 CN CN201880071851.1A patent/CN111373053B/zh active Active
- 2018-09-05 MX MX2020002643A patent/MX2020002643A/es unknown
- 2018-09-05 ES ES18779488T patent/ES3034207T3/es active Active
- 2018-09-05 FI FIEP18779488.8T patent/FI3679158T3/fi active
- 2018-09-05 US US16/644,650 patent/US20210071251A1/en active Pending
- 2018-09-05 JP JP2020513609A patent/JP7237064B2/ja active Active
- 2018-09-05 EP EP18779488.8A patent/EP3679158B1/en active Active
- 2018-09-05 NZ NZ762152A patent/NZ762152A/en unknown
- 2018-09-05 IL IL272940A patent/IL272940B2/en unknown
- 2018-09-05 KR KR1020207009809A patent/KR102752108B1/ko active Active
- 2018-09-05 AU AU2018328120A patent/AU2018328120B2/en active Active
- 2018-09-05 SG SG11202001754RA patent/SG11202001754RA/en unknown
- 2018-09-05 CA CA3074652A patent/CA3074652A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| IL272940B1 (en) | 2024-02-01 |
| SG11202001754RA (en) | 2020-03-30 |
| DK3679158T3 (da) | 2025-06-23 |
| CN111373053B (zh) | 2024-07-30 |
| JP2020537495A (ja) | 2020-12-24 |
| EP3679158B1 (en) | 2025-04-30 |
| RU2020112474A (ru) | 2021-10-06 |
| JP7237064B2 (ja) | 2023-03-10 |
| CN111373053A (zh) | 2020-07-03 |
| MX2020002643A (es) | 2020-09-25 |
| AU2018328120B2 (en) | 2024-11-14 |
| KR20200058435A (ko) | 2020-05-27 |
| NZ762152A (en) | 2025-11-28 |
| ES3034207T3 (en) | 2025-08-13 |
| CA3074652A1 (en) | 2019-03-14 |
| AU2018328120A1 (en) | 2020-03-19 |
| US20210071251A1 (en) | 2021-03-11 |
| KR102752108B1 (ko) | 2025-01-10 |
| WO2019050899A1 (en) | 2019-03-14 |
| EP3679158A1 (en) | 2020-07-15 |
| RU2020112474A3 (cg-RX-API-DMAC7.html) | 2021-12-29 |
| IL272940B2 (en) | 2024-06-01 |
| IL272940A (en) | 2020-04-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20040005560A1 (en) | Novel full-length cDNA | |
| EP1270724A2 (en) | Guanosine triphosphate-binding protein coupled receptors | |
| JP2010511382A5 (cg-RX-API-DMAC7.html) | ||
| US20170042991A1 (en) | Compositions comprising gluten peptides and uses thereof | |
| US11168345B2 (en) | Methods of identifying a polypeptide target for degradation by a modulator of CRBN | |
| JP2017502253A5 (cg-RX-API-DMAC7.html) | ||
| Pulkkinen et al. | Neuropeptide S receptor 1 (NPSR1) activates cancer-related pathways and is widely expressed in neuroendocrine tumors | |
| CN110832326A (zh) | 变态反应的抗原及其表位 | |
| Wang et al. | Arraying autoantibodies in SLE–lessons learned | |
| EP2624856B1 (en) | Moesin fragments for use in the diagnosis of immune thrombocytopenia | |
| FI3679158T3 (fi) | Yksittäisimmunoglobuliini-interleukiini-1-reseptoriin liittyvän proteiinin (SIGIRR) variantteja ja niiden käyttöjä | |
| US20170097346A1 (en) | Use of interleukin-2 for diagnosis of celiac disease | |
| EP1259539A1 (en) | Diagnosis and treatment of bipolar affective disorder | |
| US20030235833A1 (en) | Guanosine triphosphate-binding protein coupled receptors | |
| JP2009517015A5 (cg-RX-API-DMAC7.html) | ||
| KR101547307B1 (ko) | 뇌전증 진단용 바이오마커 | |
| US20030032773A1 (en) | Proteins, genes and their use for diagnosis and treatment of bipolar affective disorder (BAD) and unipolar depression | |
| US9784751B2 (en) | Method for detecting neurological disease associated with cognitive impairment by measuring EphA4 extracellular domain | |
| JP2021501601A5 (cg-RX-API-DMAC7.html) | ||
| WO2008068906A1 (ja) | 中皮腫診断剤、中皮腫診断キットおよび中皮腫診断方法 | |
| KR20100131214A (ko) | 아토피성 피부질환 진단용 마커 | |
| JP5688829B2 (ja) | 示差的な糖尿病の予知・診断方法および糖尿病予知・診断用キット | |
| JP2006071409A (ja) | シェーグレン症候群診断キット | |
| TWI606060B (zh) | 用於檢測神經性乙醯膽鹼受器阿爾法七次單位抗體之多肽分子 | |
| KR100993531B1 (ko) | 백혈병 진단용 핵산 |